FROM THE EDITOR-IN-CHIEF
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Targeted Chemotherapy | Drug Combo Targets Polyp Growth | FDA Acts to Curb Nicotine Use | Cloning Cancer | Putting Age in the Cancer Picture | Back to School | What’s Next?
The number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
YOUR CANCER GUIDE
A second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
Recognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
Janet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
Go Fish | Against the Clock
Palliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients’ values guide end-of-life decisions.
by Marci A. Landsmann
A patient support expert offers guidance on how to respond to news of a friend’s cancer diagnosis.
Help with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
Cancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
Screening reduces lung cancer mortality but is underutilized.
The Food and Drug Administration has approved a combination of two immunotherapy drugs to treat certain patients with liver cancer.
Cancer patients have a unique risk profile in this pandemic.
Handle With Care
donate to the AACR